BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8396101)

  • 1. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.
    Schaad UB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():81-8. PubMed ID: 8396101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.
    Daniel RR
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():65-71. PubMed ID: 8396099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
    Hoepelman AI; Sips AP; van Helmond JL; van Barneveld PW; Neve AJ; Zwinkels M; Rozenberg-Arska M; Verhoef J
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school.
    Khurana CM
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S24-9. PubMed ID: 8878243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media.
    Mohs E; Rodriguez-Solares A; Rivas E; el Hoshy Z
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():73-9. PubMed ID: 8396100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children.
    Aronovitz G
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S15-9. PubMed ID: 8878241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children.
    McLinn S
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S20-3. PubMed ID: 8878242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media.
    Principi N
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):669-76. PubMed ID: 8565983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media.
    Pestalozza G; Cioce C; Facchini M
    Scand J Infect Dis Suppl; 1992; 83():22-5. PubMed ID: 1336892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children.
    Hoberman A; Paradise JL; Burch DJ; Valinski WA; Hedrick JA; Aronovitz GH; Drehobl MA; Rogers JM
    Pediatr Infect Dis J; 1997 May; 16(5):463-70. PubMed ID: 9154538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA
    J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
    Zachariah J
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-amoxiclav in recurrent acute otitis media: placebo controlled study.
    Appelman CL; Claessen JQ; Touw-Otten FW; Hordijk GJ; de Melker RA
    BMJ; 1991 Dec; 303(6815):1450-2. PubMed ID: 1773154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children.
    McCarty JM; Phillips A; Wiisanen R
    Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S122-7. PubMed ID: 8295813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
    Gehanno P; Berche P; Boucot I; Lambert-Zechovsky N; Bingen E; Gres JJ; Rollin C
    J Antimicrob Chemother; 1994 Jun; 33(6):1209-18. PubMed ID: 7928814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
    Gooch WM; Blair E; Puopolo A; Paster RZ; Schwartz RH; Miller HC; Smyre HL; Yetman R; Giguere GG; Collins JJ
    Pediatr Infect Dis J; 1996 Feb; 15(2):157-64. PubMed ID: 8822290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.
    Ferwerda A; Moll HA; Hop WC; Kouwenberg JM; Tjon Pian Gi CV; Robben SG; de Groot R
    J Antimicrob Chemother; 2001 Apr; 47(4):441-6. PubMed ID: 11266417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.